{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:16Z","timestamp":1761807916454,"version":"build-2065373602"},"reference-count":20,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T00:00:00Z","timestamp":1428451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>In this post-hoc analysis of the ULIS-II study, we investigated factors influencing person-centred goal setting and achievement following botulinum toxin-A (BoNT-A) treatment in 456 adults with post-stroke upper limb spasticity (ULS). Patients with primary goals categorised as passive function had greater motor impairment (p &lt; 0.001), contractures (soft tissue shortening [STS]) (p = 0.006) and spasticity (p = 0.02) than those setting other goal types. Patients with goals categorised as active function had less motor impairment (0.0001), contracture (p &lt; 0.0001), spasticity (p &lt; 0.001) and shorter time since stroke  (p = 0.001). Patients setting goals for pain were older (p = 0.01) with more contractures  (p = 0.008). The proportion of patients achieving their primary goal was not impacted by timing of first-ever BoNT-A injection (medium-term (\u22641 year) vs. longer-term (&gt;1 year))  post-stroke (80.0% vs. 79.2%) or presence or absence of severe contractures (76.7% vs. 80.6%), although goal types differed. Earlier BoNT-A intervention was associated with greater achievement of active function goals. Severe contractures impacted negatively on goal achievement except in pain and passive function. Goal setting by patients with ULS is influenced by impairment severity, age and time since stroke. Our findings resonate with clinical experience and may assist patients and clinicians in selecting realistic, achievable goals for treatment.<\/jats:p>","DOI":"10.3390\/toxins7041192","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T11:23:46Z","timestamp":1428492226000},"page":"1192-1205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Factors Influencing Goal Attainment in Patients with  Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6508-5055","authenticated-orcid":false,"given":"Klemens","family":"Fheodoroff","sequence":"first","affiliation":[{"name":"Department of Neurorehabilitation, Gailtal-Klinik, Hermagor 9620, Austria"}]},{"given":"Stephen","family":"Ashford","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Medicine Faculty of Life Sciences and Medicine,  Department of Palliative Care, Policy and Rehabilitation, King's College London, London SE5 9PJ, UK"},{"name":"Regional Rehabilitation Unit, Northwick Park Hospital, London HA1 3UJ, UK"}]},{"given":"Jorge","family":"Jacinto","sequence":"additional","affiliation":[{"name":"Adult Rehabilitation Department 3, Alcoit\u00e3o Medical Rehabilitation Centre, Estoril 2649 506, Portugal"}]},{"given":"Pascal","family":"Maisonobe","sequence":"additional","affiliation":[{"name":"Medical Affairs, Ipsen Pharma, Boulogne-Billancourt 92650, France"}]},{"given":"Jovita","family":"Balcaitiene","sequence":"additional","affiliation":[{"name":"Medical Affairs, Ipsen Pharma, Boulogne-Billancourt 92650, France"}]},{"given":"Lynne","family":"Turner-Stokes","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Medicine Faculty of Life Sciences and Medicine,  Department of Palliative Care, Policy and Rehabilitation, King's College London, London SE5 9PJ, UK"},{"name":"Regional Rehabilitation Unit, Northwick Park Hospital, London HA1 3UJ, UK"}]}],"member":"1968","published-online":{"date-parts":[[2015,4,8]]},"reference":[{"key":"ref_1","unstructured":"National Collaborating Centre for Chronic Conditions (UK) (2008). Stroke: National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2340\/16501977-0303","article-title":"European consensus table on the use of botulinum toxin type A in adult spasticity","volume":"41","author":"Wissel","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14260","article-title":"BoTULS: A multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"14","author":"Shaw","year":"2010","journal-title":"Health Technol. Assess."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.22452","article-title":"Botulinum neurotoxins for post-stroke spasticity in adults: a systematic review","volume":"24","author":"Elia","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_7","unstructured":"Scottish Intercollegiate Guidelines Network Management of patients with stroke: Rehabilitation, prevention and management of complications, and discharge planning. A national clinical guideline. Available online:http:\/\/www.sign.ac.uk\/pdf\/sign118.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.2006.102509","article-title":"Should patients participate in clinical decision making? An optimised balance block design controlled study of goal setting in a rehabilitation unit","volume":"78","author":"Holliday","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pri.36","article-title":"Goal attainment for spasticity management using botulinum toxin","volume":"11","author":"Ashford","year":"2006","journal-title":"Physiother. Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2340\/16501977-0366","article-title":"Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes","volume":"41","author":"McCrory","year":"2009","journal-title":"J. Rehabil. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0269215508101742","article-title":"Goal attainment scaling in rehabilitation: A practical guide","volume":"23","year":"2009","journal-title":"Clin. Rehabil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2340\/16501977-1817","article-title":"Functional goal achievement in post-stroke spasticity patients: The BOTOX(R) Economic Spasticity Trial (BEST)","volume":"46","author":"Ward","year":"2014","journal-title":"J. Rehabil. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Demetrios, M., Khan, F., Turner-Stokes, L., Brand, C., and McSweeney, S. (2013). Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst. Rev., 6.","DOI":"10.1002\/14651858.CD009689.pub2"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e002230","DOI":"10.1136\/bmjopen-2012-002230","article-title":"Upper limb international spasticity study: Rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice","volume":"3","author":"Fheodoroff","year":"2013","journal-title":"BMJ Open"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e002771","DOI":"10.1136\/bmjopen-2013-002771","article-title":"Results from the upper limb international spasticity study-II (ULIS-II): A large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management","volume":"3","author":"Fheodoroff","year":"2013","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.apmr.2012.12.006","article-title":"Treatment with botulinum toxin improves upper-extremity function post stroke: A systematic review and meta-analysis","volume":"94","author":"Foley","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/1545968311430824","article-title":"Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: A randomized controlled trial","volume":"26","author":"Rosales","year":"2012","journal-title":"Neurorehabil. Neural. Repair."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0269215509358945","article-title":"Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size","volume":"24","author":"Cousins","year":"2010","journal-title":"Clin. Rehabil."},{"key":"ref_19","unstructured":"National Institute for Health and Care Excellence (NICE). Available online:http:\/\/www.nhs.uk\/NHSEngland\/thenhs\/healthregulators\/Pages\/nice.aspx."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2013.11.022","article-title":"Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: Results of the German-Austrian open-label post-marketing surveillance prospective study","volume":"337","author":"Jost","year":"2013","journal-title":"J. Neurol. Sci."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/4\/1192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:44:25Z","timestamp":1760215465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/4\/1192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,8]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4]]}},"alternative-id":["toxins7041192"],"URL":"https:\/\/doi.org\/10.3390\/toxins7041192","relation":{},"ISSN":["2072-6651"],"issn-type":[{"type":"electronic","value":"2072-6651"}],"subject":[],"published":{"date-parts":[[2015,4,8]]}}}